Ophthalmoscopy still the key to glaucoma diagnosis
Identifying glaucoma through ophthalmoscopy


Roibeard O’hEineachain
Published: Monday, July 3, 2017

The ideal diagnostic test is that it to be valid and relevant diagnosis allows staging and provide a permanent baseline against which future tests can be comparedHe noted that identifying glaucoma through ophthalmoscopy is a skill that one can acquire through viewing of optic discs of patients who definitely have glaucoma. He suggested that rather than deconstructing the images and looking for specific features like disc haemorrhages, one should learn to recognise the patterns they have in common. He likened it to the way art critics learn to identify the artist who painted a painting that they haven’t seen before. He also maintained that data from newer imaging technologies like optical coherence technology (OCT) and Heidelberg Retinal Tomography (HRT) instruments is not truly diagnostic regarding glaucoma. Opinions vary on the threshold thinness of the retinal nerve fibre layer (RNFL) for glaucomatous damage. Moreover, there are other pathologies which also cause RNFL thinning like myopia.
Latest Articles
Making Female Leadership More than a Moment
A remarkable global confluence of women in key positions.
ESCRS Talks Technology at AAO
Europe adopts technological advances, US still waiting for lenses and lasers.
Sorting Out Simultaneous Vision IOLs
The ESCRS Eye Journal Club discuss a new landmark paper on IOL classification and the need for harmonisation of terminology for presbyopic IOLs.
Big Advantages to Small-Aperture IOLs
Small-aperture IOLs offer superior image quality with increased range of focus.
Prioritising Self-Care
Benefits of maintaining physical, emotional, and mental health extend beyond the personal sphere.
Valuing Clinical Trial Design
How inclusivity and diversity can enhance scientific accuracy in research.
Knowing Iris Repair: Using Iridodiathermy in Iris Surgery
Prepare for decentred pupils and uneven irides in multiple situations.
Neuroprotectant Treatment for MacTel Type 2
Intravitreal implant releasing ciliary neurotrophic factor found safe and effective in pivotal trials.